Innoviva Inc (INVA)
19.08
-0.08
(-0.39%)
USD |
NASDAQ |
Nov 21, 16:00
19.08
0.00 (0.00%)
After-Hours: 20:00
Innoviva Price to Book Value: 1.786 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.793 |
| November 19, 2024 | 1.788 |
| November 18, 2024 | 1.774 |
| November 15, 2024 | 1.770 |
| November 14, 2024 | 1.802 |
| November 13, 2024 | 1.882 |
| November 12, 2024 | 1.903 |
| November 11, 2024 | 1.884 |
| November 08, 2024 | 1.890 |
| November 07, 2024 | 1.873 |
| November 06, 2024 | 1.865 |
| November 05, 2024 | 1.819 |
| November 04, 2024 | 1.813 |
| November 01, 2024 | 1.804 |
| October 31, 2024 | 1.832 |
| October 30, 2024 | 1.846 |
| October 29, 2024 | 1.862 |
| October 28, 2024 | 1.866 |
| October 25, 2024 | 1.851 |
| October 24, 2024 | 1.854 |
| October 23, 2024 | 1.856 |
| October 22, 2024 | 1.87 |
| October 21, 2024 | 1.859 |
| October 18, 2024 | 1.876 |
| October 17, 2024 | 1.889 |
| Date | Value |
|---|---|
| October 16, 2024 | 1.892 |
| October 15, 2024 | 1.862 |
| October 14, 2024 | 1.862 |
| October 11, 2024 | 1.854 |
| October 10, 2024 | 1.825 |
| October 09, 2024 | 1.84 |
| October 08, 2024 | 1.857 |
| October 07, 2024 | 1.848 |
| October 04, 2024 | 1.842 |
| October 03, 2024 | 1.826 |
| October 02, 2024 | 1.832 |
| October 01, 2024 | 1.826 |
| September 30, 2024 | 1.808 |
| September 27, 2024 | 1.816 |
| September 26, 2024 | 1.780 |
| September 25, 2024 | 1.773 |
| September 24, 2024 | 1.777 |
| September 23, 2024 | 1.778 |
| September 20, 2024 | 1.82 |
| September 19, 2024 | 1.849 |
| September 18, 2024 | 1.837 |
| September 17, 2024 | 1.853 |
| September 16, 2024 | 1.884 |
| September 13, 2024 | 1.862 |
| September 12, 2024 | 1.844 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.258
Minimum
Oct 27 2023
5.454
Maximum
Dec 24 2019
2.328
Average
2.151
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
| Theriva Biologics Inc | 0.1446 |
| Oragenics Inc | 2.223 |
Price to Book Value Related Metrics
| PE Ratio | 27.64 |
| PS Ratio | 3.988 |
| PEG Ratio | 0.4866 |
| Price to Free Cash Flow | 8.669 |
| Price | 19.08 |
| Earnings Yield | 3.62% |
| Market Cap | 1.194B |
| PEGY Ratio | 0.4866 |
| Operating PE Ratio | 8.724 |
| Normalized PE Ratio | 14.53 |